Medication Errors in Eight Percent of Chemotherapy Outpatient Visits

Errors in giving chemotherapy and associated medicines were found in over seven percent of adult outpatient visits and nearly twenty percent of children’s visits in a recent study. Most often, mistakes were made when changes were made to the original prescription on the day chemo was administered.  For children, about a third of mistakes happened when medicines were given at home.

Over nine months and nearly 1,400 visits, researchers found 112 medication errors.  Sixty-four of them had a the potential to harm the patient, and 15 actually did.  About 5 percent of the time, someone discovered the mistake before the medicine was actually given.

Researchers reviewed charts in four different community outpatient practices in different areas of the United States.  They looked for medication errors made in ordering, dispensing, administering, or monitoring drugs given to chemotherapy patients.  During the time covered by the study, 11,908 different medicines were given.

More than half (56 percent) of errors were made at the point of chemotherapy administration, about a third (36 percent) were due to wrong prescriptions.  Twenty percent were related to medicines used at home, most frequently in children.

The research team physicians reviewing the study information suggested interventions that might have avoided the errors including:

The outpatient clinic that used complete electronic medical records to computerize chemotherapy orders had the least administration errors.  Only one was found during 500 visits covered by the study.

At the conclusion of their study, Dr. Kathleen Walsh and her colleagues wrote,

As cancer care continues to shift from the hospital to the outpatient setting, the complexity of outpatient cancer care is growing, with increasing opportunities for medication errors, particularly in the home setting. Although national attention has focused for more than a decade on preventing inpatient chemotherapy errors, far less attention has been placed on medication errors that put patients with  cancer at risk in the clinic and home settings. The findings of our study may help to reframe medication safety priorities for patients with cancer and suggest some practical targets for intervention to improve the care of both adults and children.

SOURCE: Walsh et al., Journal of Clinical Oncology, JCO Early Release, December 29, 2008.

Bookmark and Share

This news article was originally posted on January 8th, 2009 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on January 8th, 2009
Tags: chemotherapy

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe